Elsevier

Toxicology Letters

Volume 70, Issue 2, 1 February 1994, Pages 133-138
Toxicology Letters

Minireview
Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity

https://doi.org/10.1016/0378-4274(94)90156-2Get rights and content

Abstract

About 30 different human cytochrome P450 (P450) enzymes have now been characterized in considerable detail. It is possible to elucidate their catalytic specificities towards drugs, steroids, carcinogens, and other potential substrates with in vitro assays. It is also possible to ascertain the levels of individual P450 enzymes in humans with the use of drugs, after appropriate assay validation. The ability to discern catalytic selectivity and levels of P450 enzymes within individuals offers considerable potential in drug development, prevention of undesirable drug-drug interactions, and understanding the etiology of diseases resulting from exposure to potentially toxic and carcinogenic chemicals.

References (19)

There are more references available in the full text version of this article.

Cited by (156)

  • Development of an efficient transient expression system for Siraitia grosvenorii fruit and functional characterization of two NADPH-cytochrome P450 reductases

    2021, Phytochemistry
    Citation Excerpt :

    A previous study have suggested that CPRs are indispensable for CYP450 expression (Sintupachee et al., 2014), and in various plant species, the coexpression patterns of CYP450s and CPRs have been estimated, including in S. miltiorrhiza (Guo et al., 2013), Papaver somniferum (Rosco et al., 1997) and A. thaliana (Christ et al., 2013). Generally, mammals harbour only one CPR (Guengerich, 1994), but one to four CPRs have been found in plants (Eberle et al., 2009; Shet et al., 1993), making it more difficult to determine the function of each CPR. Moreover, numerous plant CYP450s and CPRs have been previously identified and expressed in yeasts (Hamann and Møller, 2007; Jennewein et al., 2005; Urban et al., 1997) and have rarely been reported in plant-associated prokaryotic species.

  • Identification of human cytochrome P450 isozymes involved in the oxidative metabolism of carfentanil

    2021, Toxicology Letters
    Citation Excerpt :

    M13 exhibited twice the μ-opioid receptor activity as carfentanil. It is well known that cytochrome P450 (CYP) is an enzyme family consisting of multiple isoforms (Gonzalez, 1992; Guengerich, 1994) and catalyzes the biotransformation of a variety of drugs and xenobiotics (Bachmann and Ghosh, 2001). In vitro data on the major CYP isoforms involved in a drug’s metabolism are useful in predicting its metabolic fate, genetic polymorphic regulation, and potential in vivo interactions with other therapeutic agents via inductive or inhibitory mechanisms in humans (FDA, 2020; Iwatsubo et al., 1996).

  • Functional expression of two NADPH-cytochrome P450 reductases from Siraitia grosvenorii

    2018, International Journal of Biological Macromolecules
    Citation Excerpt :

    Co-expression studies have shown that the expression levels of CPRs and P450s are correlated in a linear fashion [11]. Unlike yeast and mammals that only harbor one CPR [13,14], plants may contain one to four CPR paralogous genes [15,16]. Commonly, if a plant's CPR is functionally unknown, then an Arabidopsis CPR is used to verify the functions of the plant's P450s.

  • Hepatic Drug Metabolism in Pediatric Patients

    2017, Drug Metabolism in Diseases
View all citing articles on Scopus
View full text